Amphoterin Stimulates Myogenesis and Counteracts the Antimyogenic Factors Basic Fibroblast Growth Factor and S100B via RAGE Binding

REFERENCES

• Andres, V., and Walsh K.. 1996. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J. Cell Biol. 132:657–666.
   PubMedGoogle Scholar
• Arnold, H. H., and Winter B.. 1998. Muscle differentiation: more complexity to the network of myogenic regulators. Curr. Opin. Genet. Dev. 8:539–544.
   PubMed Web of Science ®Google Scholar
• Arumugam, T., Simeone D. M., Schmidt A. M., and Logsdon C. D.. 2004. S100P stimulates cell proliferation and survival via RAGE. J. Biol. Chem. 279:5059–5065. (First published 14 November 2003; 10.1074/jbc.M310124200.)
   PubMed Web of Science ®Google Scholar
• Bennett, A. M., and Tonks N. K.. 1997. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science 278:1288–1291.
   PubMed Web of Science ®Google Scholar
• Bergstrom, D. A., Penn B. H., Strand A., Perry R. L., Rudnicki M. A., and Tapscott S. J.. 2002. Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. Mol. Cell 9:587–600.
   PubMed Web of Science ®Google Scholar
• Bour, B. A., Chakravarti M., West J. M., and Abmayr S. M.. 2000. Drosophila SNS, a member of the immunoglobulin superfamily that is essential for myoblast fusion. Genes Dev. 14:1498–1511.
   PubMedGoogle Scholar
• Brett, J., Schmidt A. M., Yan S. D., Zou Y. S., Weidman E., Pinsky D., Nowygrod R., Neeper M., Przysiecki C., and Shaw A.. 1993. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am. J. Pathol. 143:1699–1712.
   PubMed Web of Science ®Google Scholar
• Coletti, D., Yang E., Marazzi G., and Sassoon D.. 2002. TNF inhibits skeletal myogenesis through a PW1-dependent pathway by recruitment of caspase pathways. EMBO J. 21:631–642.
   PubMed Web of Science ®Google Scholar
• Coolican, S. A., Samuel D. S., Ewton D. Z., McWade F. J., and Florini J. R.. 1997. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J. Biol. Chem. 272:6653–6662.
   PubMed Web of Science ®Google Scholar
• Cuenda, A., and Cohen P.. 1999. Stress-activated protein kinase 2/p38 and rapamycin-sensitive pathway are required for C2C12 myogenesis. J. Biol. Chem. 274:4341–4346.
   PubMed Web of Science ®Google Scholar
• Donato, R. 2001. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33:637–668.
   PubMed Web of Science ®Google Scholar
• Erck, C., Meisinger C., Grothe C., and Seidl K.. 1998. Regulation of nerve growth factor and its low-affinity receptor (p75NTR) during myogenic differentiation. J. Cell. Physiol. 176:22–31.
   PubMedGoogle Scholar
• Florini, J. R., Samuel D. S., Ewton D. Z., Kirk C., and Sklar R. M.. 1996. Stimulation of myogenic differentiation by a neuregulin, glial growth factor 2. Are neuregulins the long-sought muscle trophic factors secreted by nerves? J. Biol. Chem. 271:12699–12702.
   PubMedGoogle Scholar
• Florini, J. R., Ewton D. Z., and Coolican S. A.. 1996. Growth hormone and the insulin-like growth factor system in myogenesis. Endocr. Rev. 17:481–517.
   PubMed Web of Science ®Google Scholar
• Florini, J. R., Magri K. A., Ewton D. Z., James P. L., Grindstaff K., and Rotwein P. S.. 1991. “Spontaneous” differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J. Biol. Chem. 266:15917–15923.
   PubMed Web of Science ®Google Scholar
• Foulstone, E. J., Meadows K. A., Holly J. M., and Stewart C. E.. 2001. Insulin-like growth factors (IGF-I and IGF-II) inhibit C2 skeletal myoblast differentiation and enhance TNF alpha-induced apoptosis. J. Cell. Physiol. 189:207–215.
   PubMedGoogle Scholar
• Fujio, Y., Guo K., Mano T., Mitsuuchi Y., Testa J. R., and Walsh K.. 1999. Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival. Mol. Cell. Biol. 19:5073–5082.
   PubMedGoogle Scholar
• Guo, K., Wang J., Andres V., Smith R. C., and Walsh K.. 1995. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol. Cell. Biol. 15:3823–3829.
   PubMed Web of Science ®Google Scholar
• Heizmann, C. W., Fritz G., and Schafer B. W.. 2002. S100 proteins: structure, functions and pathology. Front. Biosci. 7:d1356–1368.
   PubMed Web of Science ®Google Scholar
• Hofmann, M. A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., Avila C., Kambham N., Bierhaus A., Nawroth P., Neurath M. F., Slattery T., Beach D., McClary J., Nagashima M., Morser J., Stern D., and Schmidt A. M.. 1999. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97:889–901.
   PubMed Web of Science ®Google Scholar
• Hori, O., Brett J., Slattery T., Cao R., Zhang J., Chen J. X., Nagashima M., Lundh E. R., Vijay S., Nitecki D., Morser J., Stern D., and Schmidt A. M.. 1995. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. J. Biol. Chem. 270:25752–25761.
   PubMed Web of Science ®Google Scholar
• Huttunen, H. J., Fages C., and Rauvala H.. 1999. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-B require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 274:19919–19924.
   PubMed Web of Science ®Google Scholar
• Huttunen, H. J., Kuja-Panula J., Sorci G., Agneletti A. L., Donato R., and Rauvala H.. 2000. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through RAGE activation. J. Biol. Chem. 275:40096–40105.
   PubMed Web of Science ®Google Scholar
• Ishihara, K., Tsutsumi K., Kawane S., Nakajima M., and Kasaoka T.. 2003. The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site. FEBS Lett. 550:107–113.
   PubMed Web of Science ®Google Scholar
• Kaliman, P., Canicio J., Testar X., Palacin M., and Zorzano A.. 1999. Insulin-like growth factor-II, phosphatidylinositol 3-kinase, nuclear factor-kappaB and inducible nitric-oxide synthase define a common myogenic signaling pathway. J. Biol. Chem. 274:17437–17444.
   PubMed Web of Science ®Google Scholar
• Kallijarvi, J., Haltia M., and Baumann M. H.. 2001. Amphoterin includes a sequence motif which is homologous to the Alzheimer's-amyloid peptide (A), forms amyloid fibrils in vitro, and binds avidly to A. Biochemistry 40:10032–10037.
   PubMedGoogle Scholar
• Kang, J. S., Mulieri P. J., Miller C., Sassoon D. A., and Krauss R. S.. 1998. CDO, a robo-related cell surface protein that mediates myogenic differentiation. J. Cell Biol. 143:403–413.
   PubMedGoogle Scholar
• Kim, D., Chi S., Lee K. H., Rhee S., Kwon Y. K., Chung C. H., Kwon H., and Kang M. S.. 1999. Neuregulin stimulates myogenic differentiation in an autocrine manner. J. Biol. Chem. 274:15395–15400.
   PubMed Web of Science ®Google Scholar
• Kontaridis, M. I., Liu X., Zhang L., and Bennett A. M.. 2002. Role of SHP-2 in fibroblast growth factor receptor-mediated suppression of myogenesis in C2C12 myoblasts. Mol. Cell. Biol. 22:3875–3891.
   PubMed Web of Science ®Google Scholar
• Langen, R. C., Schols A. M., Kelders M. C., Wouters E. F., and Janssen-Heininger Y. M.. 2001. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-B. FASEB J. 15:1169–1180.
   PubMed Web of Science ®Google Scholar
• Lassar, A. B., Skapek S. X., and Novitch B.. 1994. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr. Opin. Cell Biol. 6:788–794.
   PubMed Web of Science ®Google Scholar
• Li, Y., Jiang B., Ensign W. Y., Vogt P. K., and Han J.. 2000. Myogenic differentiation requires signalling through both phosphatidylinositol 3-kinase and p38 MAP kinase. Cell. Signal. 12:751–757.
   PubMed Web of Science ®Google Scholar
• Ludolph, D. C., and Konieczny S. F.. 1995. Transcription factor families: muscling in on the myogenic program. FASEB J. 9:1595–1604.
   PubMedGoogle Scholar
• Lue, L. F., Walker D. G., Brachova L., Beach T. G., Rogers J., Schmidt A. M., Stern D. M., and Yan S. D.. 2001. Involvement of microglial receptor for advanced glycation end products (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism. Exp. Neurol. 171:29–45.
   PubMed Web of Science ®Google Scholar
• Massague, J., Cheifetz S., Endo T., and Nadal-Ginard B.. 1986. Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proc. Natl. Acad. Sci. USA 83:8206–8210.
   PubMed Web of Science ®Google Scholar
• Meriane, M., Roux P., Primig M., Fort P., and Gauthier-Rouviere C.. 2000. Critical activities of Rac1 and Cdc42Hs in skeletal myogenesis: antagonistic effects of JNK and p38 pathways. Mol. Biol. Cell 11:2513–2528.
   PubMedGoogle Scholar
• Miller, S. C., Ito H., Blau H. M., and Torti F. M.. 1988. Tumor necrosis factor inhibits human myogenesis in vitro. Mol. Cell. Biol. 8:2295–2301.
   PubMed Web of Science ®Google Scholar
• Muller, S., Scaffidi P., Degryse B., Bonaldi T., Ronfani L., Agresti A., Beltrame M., and Bianchi M. E.. 2001. The double life of HMGB1 chromatin protein: architectural factor and extracellular signal. EMBO J. 20:4337–4340.
   PubMed Web of Science ®Google Scholar
• Olson, E. N. 1992. Interplay between proliferation and differentiation within the myogenic lineage. Dev. Biol. 154:261–272.
   PubMed Web of Science ®Google Scholar
• Olson, E. N., Spizz G., and Tainsky M. A.. 1987. The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation. Mol. Cell. Biol. 7:2104–2111.
   PubMed Web of Science ®Google Scholar
• Patel, B. N., and Van Vactor D. L.. 2002. Axon guidance: the cytoplasmic tail. Curr. Opin. Cell Biol. 14:221–229.
   PubMedGoogle Scholar
• Pena, T. L., Chen S. H., Konieczny S. F., and Rane S. G.. 2000. Ras/MEK/ERK up-regulation of the fibroblast KCa channel FIK is a common mechanism for basic fibroblast growth factor and transforming growth factor-beta suppression of myogenesis. J. Biol. Chem. 275:13677–13682.
   PubMedGoogle Scholar
• Perry, R. L., Parker M. H., and Rudnicki M. A.. 2001. Activated MEK1 binds the nuclear MyoD transcriptional complex to repress transactivation. Mol. Cell 8:291–301.
   PubMed Web of Science ®Google Scholar
• Puri, P. L., Wu Z., Zhang P., Wood L. D., Bhakta K. S., Han J., Feramisco J. R., Karin M., and Wang J. Y. J.. 2000. Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. Genes Dev. 14:574–584.
   PubMed Web of Science ®Google Scholar
• Rende, M., Brizi E., Conner J., Treves S., Censier K., Provenzano C., Taglialatela G., Sanna P. P., and Donato R.. 2000. Nerve growth factor (NGF) influences differentiation and proliferation of myogenic cells in vitro via TrKA. Int. J. Dev. Neurosci. 18:869–885.
   PubMed Web of Science ®Google Scholar
• Ruiz-Gomez, M., Coutts N., Price A., Taylor M. V., and Bate M.. 2000. Drosophila dumbfounded: a myoblast attractant essential for fusion. Cell 102:189–198.
   PubMed Web of Science ®Google Scholar
• Sakaguchi, T., Yan S. F., Yan S. D., Belov D., Rong L. L., Sousa M., Andrassy M., Marso S. P., Duda S., Arnold B., Liliensiek B., Nawroth P. P., Stern D. M., Schmidt A. M., and Naka Y.. 2003. Central role of RAGE-dependent neointimal expansion in arterial restenosis. J. Clin. Investig. 111:959–972.
   PubMed Web of Science ®Google Scholar
• Schmidt, A. M., Yan S. D., Yan S. F., and Stern D.. 2000. The biology of the receptor for advanced glycation end products and its ligands. Biochim. Biophys. Acta 1498:99–111.
   PubMed Web of Science ®Google Scholar
• Schmidt, A. M., Yan S. D., Yan S. F., and Stern D. M.. 2001. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J. Clin. Investig. 108:949–955.
   PubMed Web of Science ®Google Scholar
• Seidl, K., Erck C., and Buchberger A.. 1998. Evidence for the participation of nerve growth factor and its low-affinity receptor (p75NTR) in the regulation of the myogenic program. J. Cell. Physiol. 176:10–21.
   PubMedGoogle Scholar
• Sorci, G., Riuzzi F., Agneletti A. L., Marchetti C., and Donato R.. 2003. S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner. Mol. Cell. Biol. 23:4870–4881.
   PubMedGoogle Scholar
• Sorci, G., Bianchi R., Giambanco I., Rambotti M. G., and Donato R.. 1999. Replicating myoblasts and fused myotubes express the calcium-modulated proteins S100A1 and S100B. Cell Calcium 25:93–106.
   PubMedGoogle Scholar
• Srikrishna, G., Huttunen H. J., Johansson L., Weigle B., Yamaguchi Y., Rauvala H., and Freeze H. H.. 2002. N-glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth. J. Neurochem. 80:998–1008.
   PubMed Web of Science ®Google Scholar
• Taguchi, A., Blood D. C., del Toro G., Canet A., Lee D. C., Qu W., Tanji N., Lu Y., Lalla E., Fu C., Hofmann M. A., Kislinger T., Ingram M., Lu A., Tanaka H., Hori O., Ogawa S., Stern D. M., and Schmidt A. M.. 2000. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405:354–360.
   PubMed Web of Science ®Google Scholar
• Tamir, Y., and Bengal E.. 2000. Phosphoinositide 3-kinase induces the transcriptional activity of MEF2 proteins during muscle differentiation. J. Biol. Chem. 275:34424–34432.
   PubMedGoogle Scholar
• Tortorella, L. L., Milasincic D. J., and Pilch P. F.. 2001. Critical proliferation-independent window for basic fibroblast growth factor repression of myogenesis via the p42/p44 MAPK signaling pathway. J. Biol. Chem. 276:13709–13717.
   PubMedGoogle Scholar
• Tureckova, J., Wilson E. M., Cappalonga J. L., and Rotwein P.. 2001. Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin. J. Biol. Chem. 276:39264–39270.
   PubMed Web of Science ®Google Scholar
• Wang, H., Yang H., Czura C. J., Sama A. E., and Tracey K. J.. 2001. HMGB1 as a late mediator of lethal systemic inflammation. Am. J. Respir. Crit. Care Med. 164:1768–1773.
   PubMed Web of Science ®Google Scholar
• Weintraub, H. 1993. The MyoD family and myogenesis: redundancy, networks, and thresholds. Cell 75:1241–1244.
   PubMed Web of Science ®Google Scholar
• Wendt, T., Bucciarelli L., Qu W., Lu Y., Yan S. F., Stern D. M., and Schmidt A. M.. 2002. Receptor for advanced glycation end products (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes. Curr. Atheroscler. Rep. 4:228–237.
   PubMedGoogle Scholar
• Winter, B., and Arnold H.-H.. 2000. Activated Rak kinase inhibits muscle cell differentiation through a MEF2-dependent mechanism. J. Cell Sci. 113:4211–4220.
   PubMedGoogle Scholar
• Wu, Z., Woodring P. J., Bhakta K. S., Tamura K., Wen F., Feramisco J. R., Karin M., Wang J. Y. J., and Puri P. L.. 2000. p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol. Cell. Biol. 20:3951–3964.
   PubMed Web of Science ®Google Scholar
• Xu, D., and Kyriakis J. M.. 2003. Phosphatidylinositol 3′-kinase-dependent activation of renal mesangial cell Ki-Ras and ERK by advanced glycation end products. J. Biol. Chem. 278:39349–39355.
   PubMed Web of Science ®Google Scholar
• Yan, S. D., Zhu H., Fu J., Yan S. F., Roher A., Tourtellotte W. W., Rajavashisth T., Chen X., Godman G. C., Stern D., and Schmidt A. M.. 1997. Amyloid-beta peptide-receptor for advanced glycation end product interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc. Natl. Acad. Sci. USA 94:5296–5301.
   PubMedGoogle Scholar
• Yan, S. D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., and Schmidt A. M.. 1996. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382:685–691.
   PubMed Web of Science ®Google Scholar
• Zetser, A., Gredinger E., and Bengal E.. 1999. p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor. J. Biol. Chem. 274:5193–5200.
   PubMed Web of Science ®Google Scholar